Elizabeta B Mukaetova-Ladinska
Overview
Explore the profile of Elizabeta B Mukaetova-Ladinska including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
77
Citations
1049
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Dua D, Stubbs O, Urasa S, Rogathe J, Duijinmaijer A, Howlett W, et al.
J Neurovirol
. 2023 May;
29(4):425-439.
PMID: 37227670
Studies of depression and its outcomes in older people living with HIV (PLWH) are currently lacking in sub-Saharan Africa. This study aims to investigate the prevalence of psychiatric disorders in...
12.
Mukaetova-Ladinska E, Liu Y, Venneri A
Front Aging Neurosci
. 2023 Mar;
15:1140767.
PMID: 36891554
No abstract available.
13.
Chithiramohan T, Threlfall G, Abdelaziz H, Ellahi A, Subramaniam H, Beishon L, et al.
J Alzheimers Dis
. 2023 Jan;
92(1):71-79.
PMID: 36710679
Background: The incidence of dementia in Black and Asian populations in the UK is set to rise. There is concern surrounding differences in services provided for different ethnic groups. Objective:...
14.
Hellis E, Mukaetova-Ladinska E
Medicina (Kaunas)
. 2023 Jan;
59(1).
PMID: 36676672
: People with Alzheimer's disease and dementia in general benefit from home-based care as demonstrated via their better quality of life, increased lifespan, and delayed disease progression. Since currently nearly...
15.
Santiago-Mujika E, Luthi-Carter R, Giorgini F, Mukaetova-Ladinska E
J Alzheimers Dis Rep
. 2023 Jan;
6(1):739-748.
PMID: 36606207
Background: Vascular dementia (VaD) and Alzheimer's disease (AD) are the two most common forms of dementia. Although these two types of dementia have different etiologies, they share some similarities in...
16.
Wright J, Deen Q, Stevenson A, Telford-Cooke L, Parker C, Martin-Ruiz C, et al.
J Alzheimers Dis
. 2022 Sep;
89(4):1483-1492.
PMID: 36057826
Background: Myeloperoxidase (MPO), a neutrophil-derived pro-inflammatory protein, co-localizes with amyloid-β (Aβ) plaques in Alzheimer's disease (AD). Anti-dementia treatment may facilitate efflux of Aβ and associated plaque proteins from the brain...
17.
Beishon L, Haunton V, Bradbury-Jones C, Subramaniam H, Mukaetova-Ladinska E, Panerai R, et al.
J Alzheimers Dis
. 2022 Apr;
87(3):1013-1031.
PMID: 35431250
Background: Cognitive training (CT) may be beneficial in delaying the onset or slowing dementia progression. CT has been evaluated quantitatively and qualitatively, but none have used mixed methods approaches. Objective:...
18.
Hosseini A, Brown T, Mannino L, Gran B, Junaid K, Mukaetova-Ladinska E
J Alzheimers Dis
. 2022 Apr;
87(2):771-780.
PMID: 35404281
Background: The differentiation of a preclinical or prodromal Alzheimer's disease (AD) is challenging particularly in patients with early onset Alzheimer's or related dementias (EOARD). We report our experience on diagnostic...
19.
Mukaetova-Ladinska E, De Lillo C, Arshad Q, Subramaniam H, Maltby J
Curr Alzheimer Res
. 2022 Mar;
19(4):265-273.
PMID: 35293294
No abstract available.
20.
Abdullah S, Critchfield M, Maltby J, Mukaetova-Ladinska E
J Alzheimers Dis
. 2022 Mar;
86(4):1797-1804.
PMID: 35253757
Background: Cognitive decline is classically attributed to organic causes such as dementia; however, depression can play a role in cognitive decline. Objective: To evaluate cognitive screening tools and the 4-item...